ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

Clarification: Full Text Of ACS Guideline On Prostate Screening

January 30, 1998

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982

Antigenics Begins Phase II Trial Of Oncophage for NHL.

March 31, 2000

Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects

December 30, 2011

Crout, Finkel Replaced at FDA; Hayes Combine Biologics, Drugs

April 2, 1982

32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening

September 21, 1990